Sinclair's Aloclair gets FDA OK

The UK's Sinclair Pharma has obtained clearance from the US Food and Drug Administration to market its Aloclair Spray, an over-the-counter treatment for mouth ulcers.

The approval of Aloclair spray should provide a significant boost to the company's business; in the prior financial year the rinse and gel formulations of the agent helped elicit a 150% surge in sales to L1.8 million ($3.4 million), the company said. The current global annual market for mouth ulcer treatments is estimated to be worth around $1 billion.

"Aloclair is Sinclair's biggest product at present and the addition of the spray formulation provides a range of delivery mechanisms which cover most situations for treatment of mouth ulcers," noted chief executive Michael Flynn.